SMAD4 and cancer: Expressed DPC4 (DPC4+) cancers tended to be well-defined with less peripancreatic infiltration compared to inactivated DPC4 (DPC4-) cancers (81.3% vs. 94.3%, p=0.01); however, major arterial or venous invasions did not differ between the two groups.